Tech Company Inital Public Offerings
Rain Therapeutics IPO
Rain Therapeutics was purchased by . Shares were listed on 4/23/2021.
Transaction Overview
Company Name
Announced On
4/23/2021
Transaction Type
IPO
Amount
$125,800,000
Proceeds Purpose
Use of proceeds for the Rain Therapeutics IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
8000 Jarvis Ave. 204
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Website
Email Address
Overview
Rain Therapeutics Inc. is a privately-held biotechnology company developing biomarker-driven small molecule therapeutics for patients with cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Avanish Vellanki
Co-Founder
Robert Doebele
Browse more venture capital transactions:
Prev: 4/23/2021: Kandji venture capital transaction
Next: 4/23/2021: Sift venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs